Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 5 studies | 23% ± 6% | |
glutamatergic neuron | 4 studies | 42% ± 16% | |
oligodendrocyte | 4 studies | 19% ± 2% | |
classical monocyte | 3 studies | 17% ± 1% | |
GABAergic neuron | 3 studies | 40% ± 5% | |
dendritic cell | 3 studies | 25% ± 6% | |
macrophage | 3 studies | 16% ± 1% | |
neuron | 3 studies | 21% ± 5% | |
natural killer cell | 3 studies | 17% ± 1% | |
astrocyte | 3 studies | 24% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 36% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 1190.80 | 226 / 226 | 100% | 16.33 | 405 / 406 |
breast | 100% | 1749.19 | 459 / 459 | 100% | 34.77 | 1115 / 1118 |
uterus | 100% | 1796.39 | 170 / 170 | 100% | 27.12 | 457 / 459 |
thymus | 100% | 1468.74 | 652 / 653 | 100% | 21.91 | 603 / 605 |
intestine | 100% | 1697.77 | 966 / 966 | 99% | 26.49 | 524 / 527 |
prostate | 100% | 1414.15 | 244 / 245 | 100% | 23.55 | 501 / 502 |
ovary | 100% | 1293.41 | 180 / 180 | 99% | 19.29 | 427 / 430 |
adrenal gland | 100% | 2556.24 | 258 / 258 | 99% | 22.65 | 228 / 230 |
kidney | 100% | 1288.56 | 89 / 89 | 99% | 19.10 | 893 / 901 |
stomach | 100% | 1336.27 | 358 / 359 | 99% | 24.73 | 284 / 286 |
bladder | 100% | 1761.81 | 21 / 21 | 99% | 23.32 | 499 / 504 |
lung | 100% | 1620.59 | 578 / 578 | 99% | 23.09 | 1140 / 1155 |
brain | 99% | 1127.65 | 2611 / 2642 | 99% | 19.59 | 700 / 705 |
esophagus | 100% | 1756.61 | 1445 / 1445 | 98% | 24.45 | 179 / 183 |
pancreas | 99% | 922.28 | 324 / 328 | 99% | 18.11 | 176 / 178 |
skin | 100% | 2114.03 | 1809 / 1809 | 97% | 19.94 | 457 / 472 |
adipose | 100% | 1841.97 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2034.14 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 26.23 | 29 / 29 |
muscle | 100% | 4477.36 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 1507.53 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 27.95 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.35 | 1 / 1 |
heart | 97% | 1593.55 | 836 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 15.36 | 76 / 80 |
peripheral blood | 93% | 1287.87 | 862 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1903423 | Biological process | positive regulation of synaptic vesicle recycling |
GO_0006954 | Biological process | inflammatory response |
GO_1900045 | Biological process | negative regulation of protein K63-linked ubiquitination |
GO_2001224 | Biological process | positive regulation of neuron migration |
GO_0007165 | Biological process | signal transduction |
GO_0016236 | Biological process | macroautophagy |
GO_1903861 | Biological process | positive regulation of dendrite extension |
GO_0043162 | Biological process | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway |
GO_0010992 | Biological process | ubiquitin recycling |
GO_0032430 | Biological process | positive regulation of phospholipase A2 activity |
GO_0006693 | Biological process | prostaglandin metabolic process |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0007399 | Biological process | nervous system development |
GO_0043161 | Biological process | proteasome-mediated ubiquitin-dependent protein catabolic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0045202 | Cellular component | synapse |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0016005 | Molecular function | phospholipase A2 activator activity |
GO_0005515 | Molecular function | protein binding |
GO_0043130 | Molecular function | ubiquitin binding |
Gene name | PLAA |
Protein name | Phospholipase A2 activating protein Phospholipase A-2-activating protein (PLA2P) (PLAP) |
Synonyms | PLAP |
Description | FUNCTION: Plays a role in protein ubiquitination, sorting and degradation through its association with VCP . Involved in ubiquitin-mediated membrane proteins trafficking to late endosomes in an ESCRT-dependent manner, and hence plays a role in synaptic vesicle recycling (By similarity). May play a role in macroautophagy, regulating for instance the clearance of damaged lysosomes . Plays a role in cerebellar Purkinje cell development (By similarity). Positively regulates cytosolic and calcium-independent phospholipase A2 activities in a tumor necrosis factor alpha (TNF-alpha)- or lipopolysaccharide (LPS)-dependent manner, and hence prostaglandin E2 biosynthesis . . |
Accessions | ENST00000487173.5 H0YC16 H0YBW4 ENST00000517642.5 ENST00000520884.5 H0YAU9 Q9Y263 ENST00000523212.1 ENST00000397292.8 E5RIM3 |